Benchmark Financial Wealth Advisors, LLC Pfizer Inc Transaction History

Benchmark Financial Wealth Advisors, LLC

$299 Million
Q3 2024

A detailed history of Benchmark Financial Wealth Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Benchmark Financial Wealth Advisors, LLC holds 15,248 shares of PFE stock, worth $400,107. This represents 0.15% of its overall portfolio holdings.

Number of Shares

15,248

Previous 15,403 1.01%

Holding current value

$400,107

Previous $430,000 2.56%

% of portfolio

0.15%

Previous 0.16%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$27.7 - $31.39 $4,293 - $4,865	-155 Reduced 1.01%	15,248 $441,000
Q2 2024 Jul 23, 2024	SELL	$25.26 - $29.6 $631 - $740	-25 Reduced 0.16%	15,403 $430,000
Q1 2024 Apr 22, 2024	BUY	$25.89 - $29.73 $188,453 - $216,404	7,279 Added 89.32%	15,428 $428,000
Q4 2023 Jan 23, 2024	BUY	$26.13 - $33.94 $212,933 - $276,577	8,149 New	8,149 $234,000
Q2 2023 Jul 25, 2023	SELL	$36.12 - $41.79 $11,486 - $13,289	-318 Reduced 4.43%	6,860 $251,000
Q1 2023 Apr 28, 2023	SELL	$39.39 - $51.28 $4,372 - $5,692	-111 Reduced 1.52%	7,178 $292,000
Q4 2022 Jan 23, 2023	SELL	$41.75 - $54.5 $23,588 - $30,792	-565 Reduced 7.19%	7,289 $0
Q3 2022 Nov 01, 2022	BUY	$43.76 - $53.42 $19,648 - $23,985	449 Added 6.06%	7,854 $344,000
Q2 2022 Jul 22, 2022	BUY	$46.53 - $55.17 $24,567 - $29,129	528 Added 7.68%	7,405 $388,000
Q1 2022 Apr 22, 2022	SELL	$45.75 - $56.69 $10,568 - $13,095	-231 Reduced 3.25%	6,877 $356,000
Q4 2021 Jan 26, 2022	SELL	$41.32 - $61.25 $1,156 - $1,715	-28 Reduced 0.39%	7,108 $420,000
Q3 2021 Oct 26, 2021	BUY	$39.25 - $50.42 $27,671 - $35,546	705 Added 10.96%	7,136 $307,000
Q2 2021 Jul 26, 2021	BUY	$35.91 - $40.68 $16,590 - $18,794	462 Added 7.74%	6,431 $252,000
Q1 2021 Apr 26, 2021	SELL	$33.49 - $37.77 $15,237 - $17,185	-455 Reduced 7.08%	5,969 $216,000
Q4 2020 Jan 20, 2021	BUY	$33.47 - $42.56 $3,949 - $5,022	118 Added 1.87%	6,424 $236,000
Q3 2020 Oct 15, 2020	SELL	$31.75 - $37.25 $13,049 - $15,309	-411 Reduced 6.12%	6,306 $231,000
Q2 2020 Jul 21, 2020	BUY	$30.12 - $36.54 $202,316 - $245,439	6,717 New	6,717 $220,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.73B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $147B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Benchmark Financial Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Benchmark Financial Wealth Advisors, LLC with notifications on news.

Account

Benchmark Financial Wealth Advisors, LLC Pfizer Inc Transaction History